{"id":287387,"date":"2023-01-03T16:31:21","date_gmt":"2023-01-03T13:31:21","guid":{"rendered":"http:\/\/107.6.182.27\/fr\/?p=287387"},"modified":"2023-01-03T16:31:21","modified_gmt":"2023-01-03T13:31:21","slug":"innovation-dun-medicament-qui-evite-la-perte-de-vision-due-a-une-maladie-courante","status":"publish","type":"post","link":"https:\/\/archive.sana.sy\/fr\/?p=287387","title":{"rendered":"Innovation d\u2019un m\u00e9dicament qui \u00e9vite la perte de vision due \u00e0 une maladie courante"},"content":{"rendered":"<p>Berne-SANA\/Un certain nombre de scientistes ont innov\u00e9 un nouveau m\u00e9dicament qui ralentit la progression d&#8217;un probl\u00e8me oculaire fr\u00e9quent. Cette innovation pourrait sauver des milliers de personnes \u00e0 risque de devenir aveugles \u00e0 cause des injections mensuelles.<\/p>\n<p>Selon l\u2019entreprise pharmaceutique suisse \u00ab Hoffmann-La Roche \u00bb, qui a d\u00e9velopp\u00e9 le m\u00e9dicament, le nouveau m\u00e9dicament nomm\u00e9 \u00abVarisimab \u00bb peut \u00e9viter la d\u00e9t\u00e9rioration de la vision plus efficacement et sans avoir besoin de doses mensuelles, notamment chez les personnes \u00e2g\u00e9es qui souffrent d&#8217;occlusion veineuse r\u00e9tinienne ,qui cause une perte de vision progressive, et ce avec seulement 3 doses par an.<\/p>\n<p>Les experts disent que le m\u00e9dicament repr\u00e9sente une &#8221; grande d\u00e9tente&#8221; pour les patients souffrant de cette maladie, qui survient lorsqu&#8217;un petit vaisseau sanguin \u00e0 l&#8217;arri\u00e8re de l&#8217;\u0153il est bloqu\u00e9 par un caillot, provoquant une fuite de sang et d&#8217;autres fluides dans la r\u00e9tine.<\/p>\n<p>B.D.\/L.A.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Berne-SANA\/Un certain nombre de scientistes ont innov\u00e9 un nouveau m\u00e9dicament qui ralentit la progression d&#8217;un probl\u00e8me oculaire fr\u00e9quent. Cette innovation pourrait sauver des milliers de personnes \u00e0 risque de devenir aveugles \u00e0 cause des injections mensuelles. Selon l\u2019entreprise pharmaceutique suisse \u00ab Hoffmann-La Roche \u00bb, qui a d\u00e9velopp\u00e9 le m\u00e9dicament, le nouveau m\u00e9dicament nomm\u00e9 \u00abVarisimab \u00bb &hellip;<\/p>\n","protected":false},"author":1,"featured_media":287388,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5924,549,548,617],"tags":[],"class_list":["post-287387","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-les-dernieres-nouvelles","category-nouvelles-et-rapports-sante-et-environnement","category-sante-et-environnement","category-ticker"],"_links":{"self":[{"href":"https:\/\/archive.sana.sy\/fr\/index.php?rest_route=\/wp\/v2\/posts\/287387"}],"collection":[{"href":"https:\/\/archive.sana.sy\/fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/archive.sana.sy\/fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/archive.sana.sy\/fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/archive.sana.sy\/fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=287387"}],"version-history":[{"count":0,"href":"https:\/\/archive.sana.sy\/fr\/index.php?rest_route=\/wp\/v2\/posts\/287387\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/archive.sana.sy\/fr\/index.php?rest_route=\/wp\/v2\/media\/287388"}],"wp:attachment":[{"href":"https:\/\/archive.sana.sy\/fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=287387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/archive.sana.sy\/fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=287387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/archive.sana.sy\/fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=287387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}